Enigma of autism regression mechanistic pathways, clinical phenotypes, and early intervention implications

Table 8 Clinical integration of autism regression for pediatric practice

Domain	Key mechanisms (evidence-aligned)	Clinical red flags	Diagnostic priorities (selective)	Intervention implications
Synaptic/network development	Dysregulated synaptic pruning; impaired long-range connectivity (human imaging, post-mortem, animal models)	Loss of words or social engagement between 12-30 months; plateau followed by decline	Developmental trajectory review; exclude progressive neurological signs	Immediate early intervention (NDBI, speech therapy); avoid watchful waiting
Excitatory-inhibitory balance/epileptiform activity	GABA-glutamate imbalance; sleep-related epileptiform discharges (observational + EEG studies)	Loss of receptive language; fluctuating cognition; sleep disturbance; behavioral arrest	Overnight or prolonged sleep EEG (not routine EEG)	Treat epileptiform activity if present; optimize sleep; supports learning capacity
Immune/neuroinflammatory pathways	Microglial activation; cytokine imbalance (associative human studies)	Regression temporally associated with infection; irritability; sleep or behavioral change	Targeted evaluation only if systemic or neurological features present	Stabilize biological stressors; avoid implying causality; focus on developmental therapy
Mitochondrial/metabolic vulnerability	Impaired energy metabolism during physiological stress (case series, cohort data)	Regression after febrile illness; lethargy; motor decline; GI symptoms	Metabolic testing only if systemic red flags (e.g., episodic decompensation)	Treat comorbidities; ensure nutrition and energy balance; supports therapy engagement
Gut-brain-immune axis	Dysbiosis; microbial metabolites; gut permeability (associative evidence)	Chronic GI symptoms with regression; feeding intolerance	GI evaluation guided by symptoms; no routine microbiome testing	Symptom-directed GI care; improves comfort and therapy participation
Genetic/epigenetic susceptibility	De novo variants; epigenetic unmasking during critical windows	Syndromic features; motor regression; abnormal head growth; family history	Chromosomal microarray ± exome sequencing (risk-stratified)	Etiologic clarity; prognosis; family counseling; individualized planning
Developmental trajectory (cross-cutting)	Multi-hit model during critical neuroplastic window	Any documented loss of previously acquired skills	Parallel diagnostic + intervention pathways	Early, intensive, parent-mediated intervention regardless of diagnosis

NDBI: Naturalistic developmental behavioral intervention; GABA: Gamma-aminobutyric acid; EEG: Electroencephalogram; GI: Gastrointestinal.